(Q35119398)

6 August 2017

0 references

1 reference

title

Reconstructive neurosurgery for Parkinson's disease: a systematic review and preliminary meta-analysis (English)

1 reference

6 August 2017

Reconstructive neurosurgery for Parkinson’s disease: a systematic review and preliminary meta-analysis (English)

1 reference

https://api.crossref.org/works/10.1016/S0361-9230(03)00017-0

29 December 2023

0 references

1 reference

1 reference

1 reference

2

M. E. Morris

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12725889

29 December 2023

3

S. Reilly

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12725889

29 December 2023

4

B. Bilney

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12725889

29 December 2023

author name string

S. Polgar

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12725889

29 December 2023

P. R. Sanberg

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12725889

29 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12725889

29 December 2023

publication date

1 April 2003

1 reference

6 August 2017

15 April 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12725889

full work available at URL

29 December 2023

https://api.elsevier.com/content/article/PII:S0361923003000170?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0361-9230(03)00017-0

https://api.elsevier.com/content/article/PII:S0361923003000170?httpAccept=text/plain

29 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0361-9230(03)00017-0

29 December 2023

published in

Brain Research Bulletin

1 reference

6 August 2017

60

1 reference

6 August 2017

1-2

1 reference

6 August 2017

1-24

1 reference

Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Activation of neurotransplants in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Transplantation therapy for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Development of fetal neural transplantation as a treatment for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Long-term outcome of unilaterally transplanted parkinsonian patients. I. Clinical approach.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD).

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Transplantation of embryonic dopamine neurons: what we know from rats

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Transplantation of human fetal dopamine cells for Parkinson's disease. Results at 1 year

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Transplantation of fetal mesencephalic tissue in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Transplantation of embryonic dopamine neurons for severe Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

From transplants to gene therapy for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Peer review for fetal tissue transplantation research

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Development of dopaminergic neurons in the human substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Sequential bilateral transplantation in Parkinson's disease: effects of the second graft.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Implantation of human fetal ventral mesencephalon to the right caudate nucleus in advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Clinical study of fetal mesencephalic intracerebral transplants for the treatment of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Outcome following intrastriatal fetal mesencephalic grafts for Parkinson's patients is directly related to the volume of grafted tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Dopaminergic transplants in patients with Parkinson's disease: neuroanatomical correlates of clinical recovery

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Functional fetal nigral grafts in a patient with Parkinson's disease: chemoanatomic, ultrastructural, and metabolic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Surgery for Parkinson disease: A critical evaluation of the state of the art.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

The core assessment program for intracerebral transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Core assessment program for intracerebral transplantations (CAPIT)

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Cerebral implantation in movement disorders: state of the art.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Long-term improvement in patients with severe Parkinson's disease after implantation of fetal ventral mesencephalic tissue in a cavity of the caudate nucleus: 5-year follow up in 10 patients. Clinica Puerta de Hierro Neural Transplantation Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Transplantation of fetal mesencephalic tissue in Parkinson's patients

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

1 reference

7 January 2021

Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Precursor cells for transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Clinical correlates of [18F]fluorodopa uptake in five grafted parkinsonian patients

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Long-term treatment with dopamine agonists in idiopathic Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Economic and health-related quality of life considerations of new therapies in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Impact of Parkinson's disease and its pharmacologic treatment on quality of life and economic outcomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

What contributes to quality of life in patients with Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Meta-analysis of the literature or of individual patient data: is there a difference?

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Fetal tissue transplantation [correction of transplanation] in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Deep brain stimulation in the treatment of Parkinson's disease: a cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Placebo surgery in trials of therapy for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Sertoli cell transplants: their use in the treatment of neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

A long term follow-up of fetal dopaminergic neurons transplantation into the brain of three parkinsonian patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900017-0

7 January 2021

Q64797276

series ordinal

65

1 reference

https://api.crossref.org/works/10.1016/S0361-9230(03)00017-0

29 December 2023

Identifiers

1 reference

6 August 2017

1 reference